EA200200151A1 - Сухая порошкообразная композиция - Google Patents
Сухая порошкообразная композицияInfo
- Publication number
- EA200200151A1 EA200200151A1 EA200200151A EA200200151A EA200200151A1 EA 200200151 A1 EA200200151 A1 EA 200200151A1 EA 200200151 A EA200200151 A EA 200200151A EA 200200151 A EA200200151 A EA 200200151A EA 200200151 A1 EA200200151 A1 EA 200200151A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- dry powder
- powder composition
- carbohydrate
- agent
- hydrophobic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/541—Organic ions forming an ion pair complex with the pharmacologically or therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
- A61K47/544—Phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Гидрофильный терапевтический агент получают в устойчивой при хранении форме, подходящей для введения пациенту. Агент состоит из гидрофобно дериватизированного углевода с использованием образования ионных пар для получения раствора агента и углевода.Международная заявка была опубликована вместе с отчетом о международном поиске.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9916316.4A GB9916316D0 (en) | 1999-07-12 | 1999-07-12 | Dry powder compositions |
PCT/GB2000/002661 WO2001003673A1 (en) | 1999-07-12 | 2000-07-11 | Dry powder compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200200151A1 true EA200200151A1 (ru) | 2002-06-27 |
Family
ID=10857101
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200200151A EA200200151A1 (ru) | 1999-07-12 | 2000-07-11 | Сухая порошкообразная композиция |
Country Status (12)
Country | Link |
---|---|
US (1) | US6551622B1 (ru) |
EP (1) | EP1194126A1 (ru) |
JP (1) | JP2003504325A (ru) |
CN (1) | CN1360496A (ru) |
AU (1) | AU766042B2 (ru) |
BR (1) | BR0012444A (ru) |
CA (1) | CA2375640A1 (ru) |
EA (1) | EA200200151A1 (ru) |
GB (1) | GB9916316D0 (ru) |
IL (1) | IL147390A0 (ru) |
MX (1) | MXPA02000500A (ru) |
WO (1) | WO2001003673A1 (ru) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6503231B1 (en) * | 1998-06-10 | 2003-01-07 | Georgia Tech Research Corporation | Microneedle device for transport of molecules across tissue |
US6611707B1 (en) | 1999-06-04 | 2003-08-26 | Georgia Tech Research Corporation | Microneedle drug delivery device |
GB0020616D0 (en) * | 2000-08-21 | 2000-10-11 | Quadrant Holdings Cambridge | Particulates |
WO2002064193A2 (en) * | 2000-12-14 | 2002-08-22 | Georgia Tech Research Corporation | Microneedle devices and production thereof |
KR20050044523A (ko) * | 2001-11-19 | 2005-05-12 | 벡톤 디킨슨 앤드 컴퍼니 | 입자 형태의 약제학적 조성물 |
GB0208608D0 (en) * | 2002-04-13 | 2002-05-22 | Glaxo Group Ltd | Composition |
GB0208609D0 (en) * | 2002-04-13 | 2002-05-22 | Glaxo Group Ltd | Compositions |
US9339459B2 (en) | 2003-04-24 | 2016-05-17 | Nektar Therapeutics | Particulate materials |
BRPI0412029A (pt) * | 2003-06-30 | 2006-09-05 | Alza Corp | formulações para microprojeções revestidas contendo contra-ìons não-voláteis |
JP2007503268A (ja) * | 2003-08-25 | 2007-02-22 | スリーエム イノベイティブ プロパティズ カンパニー | 免疫応答修飾化合物の送達 |
US20070172517A1 (en) * | 2003-09-17 | 2007-07-26 | Ben-Sasson Shmuel A | Compositions capable of facilitation penetration across a biological barrier |
GB0416861D0 (en) * | 2004-07-29 | 2004-09-01 | Quadrant Drug Delivery Ltd | Composition |
WO2006076222A2 (en) * | 2005-01-10 | 2006-07-20 | Glaxo Group Limited | Pharmaceutical formulations |
WO2007061781A1 (en) * | 2005-11-18 | 2007-05-31 | 3M Innovative Properties Company | Coatable compositions, coatings derived therefrom and microarrays having such coatings |
US20080319404A1 (en) * | 2005-12-21 | 2008-12-25 | Pekurovsky Mikhail L | Microneedle Devices |
US20120064126A1 (en) * | 2009-03-26 | 2012-03-15 | Pulmatrix, Inc. | Dry powder formulations and methods for treating pulmonary diseases |
TWM410270U (en) * | 2011-04-13 | 2011-08-21 | Darfon Electronics Corp | Foldable keyboard assembly and portable electronic module |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4880635B1 (en) * | 1984-08-08 | 1996-07-02 | Liposome Company | Dehydrated liposomes |
US5260273A (en) * | 1988-01-06 | 1993-11-09 | The Scripps Research Institute | Pulmonary surfactant protein and related polypeptide |
US5652122A (en) * | 1989-12-21 | 1997-07-29 | Frankel; Alan | Nucleic acids encoding and methods of making tat-derived transport polypeptides |
US5994314A (en) * | 1993-04-07 | 1999-11-30 | Inhale Therapeutic Systems, Inc. | Compositions and methods for nucleic acid delivery to the lung |
IS1796B (is) * | 1993-06-24 | 2001-12-31 | Ab Astra | Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband |
ATE416755T1 (de) * | 1994-03-07 | 2008-12-15 | Nektar Therapeutics | Verfahren und zusammensetzung für die pulmonale darreichung von insulin |
GB2288732B (en) | 1994-04-13 | 1998-04-29 | Quadrant Holdings Cambridge | Pharmaceutical compositions |
US5955448A (en) | 1994-08-19 | 1999-09-21 | Quadrant Holdings Cambridge Limited | Method for stabilization of biological substances during drying and subsequent storage and compositions thereof |
EP0773781B1 (en) | 1994-08-04 | 2003-10-22 | Elan Drug Delivery Limited | Solid delivery systems for controlled release of molecules incorporated therein and methods of making same |
US6586006B2 (en) | 1994-08-04 | 2003-07-01 | Elan Drug Delivery Limited | Solid delivery systems for controlled release of molecules incorporated therein and methods of making same |
WO1996027393A1 (en) * | 1995-03-07 | 1996-09-12 | University Of Pittsburgh | A dry powder formulation for gene therapy |
US5811406A (en) * | 1995-06-07 | 1998-09-22 | Regents Of The University Of California | Dry powder formulations of polynucleotide complexes |
US5958455A (en) | 1996-02-09 | 1999-09-28 | Quadrant Holdings Cambridge Ltd | Oral solid dosage forms, methods of making same and compositions thereof |
US6093816A (en) * | 1996-06-27 | 2000-07-25 | Isis Pharmaceuticals, Inc. | Cationic lipids |
ZA9711732B (en) * | 1996-12-31 | 1998-12-28 | Quadrant Holdings Cambridge | Methods and compositions for improvement bioavailability of bioactive agents for mucosal delivery |
EP0994887B1 (en) | 1997-07-03 | 2002-11-27 | Elan Drug Delivery Limited | Modified glycosides, compositions comprised thereof and methods of use thereof |
US6352722B1 (en) * | 1997-12-23 | 2002-03-05 | Quadrant Holdings Cambridge Limited | Derivatized carbohydrates, compositions comprised thereof and methods of use thereof |
-
1999
- 1999-07-12 GB GBGB9916316.4A patent/GB9916316D0/en not_active Ceased
-
2000
- 2000-07-11 IL IL14739000A patent/IL147390A0/xx unknown
- 2000-07-11 MX MXPA02000500A patent/MXPA02000500A/es unknown
- 2000-07-11 BR BR0012444-3A patent/BR0012444A/pt not_active IP Right Cessation
- 2000-07-11 AU AU61666/00A patent/AU766042B2/en not_active Ceased
- 2000-07-11 CA CA002375640A patent/CA2375640A1/en not_active Abandoned
- 2000-07-11 WO PCT/GB2000/002661 patent/WO2001003673A1/en not_active Application Discontinuation
- 2000-07-11 JP JP2001508954A patent/JP2003504325A/ja not_active Abandoned
- 2000-07-11 CN CN00810245A patent/CN1360496A/zh active Pending
- 2000-07-11 EP EP00948092A patent/EP1194126A1/en not_active Withdrawn
- 2000-07-11 EA EA200200151A patent/EA200200151A1/ru unknown
- 2000-07-12 US US09/614,233 patent/US6551622B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2375640A1 (en) | 2001-01-18 |
US6551622B1 (en) | 2003-04-22 |
BR0012444A (pt) | 2002-04-02 |
EP1194126A1 (en) | 2002-04-10 |
JP2003504325A (ja) | 2003-02-04 |
CN1360496A (zh) | 2002-07-24 |
WO2001003673A1 (en) | 2001-01-18 |
AU766042B2 (en) | 2003-10-09 |
IL147390A0 (en) | 2002-08-14 |
GB9916316D0 (en) | 1999-09-15 |
MXPA02000500A (es) | 2005-08-16 |
AU6166600A (en) | 2001-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200200151A1 (ru) | Сухая порошкообразная композиция | |
BG60102B2 (bg) | Метод за получаване на 5-флуор-2(((4-циклопропил- метокси-2-пиридинил)метил)тионил)-1н-бензимидазол | |
ES2152412T3 (es) | Preparacion farmaceuticamente estable de oxaliplatino. | |
SE8702907D0 (sv) | Stable pharmaceutical preparation containing granulocyte colony stimulating factor and process for producing the same | |
BR9702362A (pt) | Novas fomrulações lìquidas estáveis à base de paracetamol e seu modo de preparação. | |
HN1999000159A (es) | Administracion de agente activo en polvo seco. | |
ES2150438T3 (es) | Composicion de esferonizacion a base de celulosa microcristalina. | |
KR900700089A (ko) | 전신성 피부 투과적 투여를 위한 약학적 조성물 | |
BR0109346A (pt) | Combinações de substâncias ativas com propriedades inseticidas e acaricidas | |
EA200101206A1 (ru) | Применение биоразлагаемых микросфер, высвобождающих противораковый агент, для лечения глиобластомы | |
ES2179832T3 (es) | Formas de administracion orales con contenido en flupirtina solida, con liberacion controlada del principio activo. | |
BR0109515A (pt) | Derivados da apomorfina e métodos para seu uso | |
FI940696A (fi) | Uudet pyratsiinijohdannaiset, niiden valmistus ja käyttö | |
EA199900376A1 (ru) | Местный анестетик для наружного применения | |
EA200201044A1 (ru) | Фармацевтическая композиция с контролируемым высвобождением, содержащая мидодрин и/или десглимидодрин | |
ES2033021T3 (es) | Agente con efecto destructivo a tumores malignos, procedimiento para su obtencion y preparacion para la aplicacion en la terapia de enfermos de cancer. | |
ES2125696T3 (es) | Utilizacion del cloruro de tropsio para la produccion de una preparacion farmaceutica para el tratamiento de disfunciones vesicales. | |
AR006892A1 (es) | Uso de formas del acido hialuronico (ha) para el tratamiento del cancer | |
IL152328A (en) | Preparations containing a combination of defibrotide and one or more hematopoietic factors and their use | |
PE22995A1 (es) | Composicion de tiotepa liofilizada estable | |
LV11818A (lv) | Jauna farmaceitiska kompozicija stabilas pulverveida zalu formas pagatavosanai | |
EA200100214A1 (ru) | Применение производных камптотецина с пониженной гастроинтестинальной токсичностью | |
DK0450123T3 (da) | Farmaceutisk præparat til topisk administration indeholdende dichlofenac-natrium | |
TR200000890T2 (tr) | Topik ilacın üretilmesi için -amino levülozik asidin kullanılması | |
DE60135845D1 (de) | Pralmorelin-haltige nasentropfen-präparate |